Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 3/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.79 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.79 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.79 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.79 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.79 |
| ▸ | STAT3 | P40763 | 2/20 | 0.79 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.79 |
| ▸ | RELA | Q04206 | 2/20 | 0.79 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.79 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.77 |
| ▸ | CA12 | O43570 | 2/20 | 0.77 |
| ▸ | CA1 | P00915 | 2/20 | 0.77 |
| ▸ | CA2 | P00918 | 2/20 | 0.77 |
| ▸ | CA3 | P07451 | 2/20 | 0.77 |
| ▸ | PKM | P14618 | 2/20 | 0.77 |
| ▸ | CA4 | P22748 | 2/20 | 0.77 |
| ▸ | CA6 | P23280 | 2/20 | 0.77 |
| ▸ | CA5A | P35218 | 2/20 | 0.77 |
| ▸ | SNCA | P37840 | 2/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dehydrozingerone SCHEMBL30310276 | 1.00 | APP (1.00) | APPCYP2D6NFKB1CYP1A2ALOX5 | |
| Dehydrozingerone SCHEMBL29691993 | 1.00 | APP (1.00) | APPCYP2D6NFKB1CYP1A2ALOX5 | |
| Dehydrozingerone SCHEMBL498224 | 1.00 | APP (1.00) | APPCYP2D6NFKB1CYP1A2ALOX5 | |
| Dehydrozingerone SCHEMBL9104958 | 0.98 | APP (0.97) | APPCYP2D6NFKB1CYP1A2ALOX5 | |
| Dehydrozingerone SCHEMBL27764046 | 0.91 | APP (0.83) | APPCYP2D6NFKB1CYP1A2ALOX5 | |
| SCHEMBL29478095 | 0.88 | CYP2D6 (1.00) | APPCYP2D6NFKB1CYP1A2ALOX5 | |
| SCHEMBL1493283 | 0.88 | CYP2D6 (1.00) | APPCYP2D6NFKB1CYP1A2ALOX5 | |
| SCHEMBL1493282 | 0.88 | CYP2D6 (1.00) | APPCYP2D6NFKB1CYP1A2ALOX5 | |
| SCHEMBL30668505 | 0.88 | CYP2D6 (1.00) | APPCYP2D6NFKB1CYP1A2ALOX5 | |
| SCHEMBL9907021 | 0.88 | APP (0.78) | APPCYP2D6NFKB1CYP1A2ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 468 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260130864-A1 | METHOD AND COMPOSITION FOR ENHANCING EXERCISE PERFORMANCE | NANJING NUTRABUILDING BIO TECH CO LTD (CN) | 2026-05-14 | — | — | US | claimed |
| US-20250327100-A1 | Strain of Pseudomonas Putida Genetically Modified to Express a Benzalacetone Reductase | BGENE GENETICS (FR) | 2025-10-23 | — | — | US | claimed |
| US-20250033082-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2025-01-30 | — | — | US | claimed |
| EP-4464696-A1 | CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD FOR PREPARING SAME, EPOXY COMPOSITE MATERIAL COMPRISING SAME, AND DECOMPOSITION METHOD THEREOF | Konkuk University Industrial Cooperation Corp. (KR) | 2024-11-20 | — | — | EP | claimed |
| CN-118201991-A | Methods and compositions for reducing solvent release from agrochemical formulations and reducing agrochemical formulation odor | 安道麦马克西姆有限公司 | 2024-06-14 | — | — | CN | claimed |
| EP-4370674-A1 | STRAIN OF PSEUDOMONAS PUTIDA GENETICALLY MODIFIED TO EXPRESS A BENZALACETONE REDUCTASE | BGene Genetics (FR) | 2024-05-22 | — | — | EP | claimed |
| CN-117653618-A | Novel benzalacetone derivative and use thereof | 韩药有限公司 | 2024-03-08 | — | — | CN | claimed |
| US-20230364069-A1 | METHOD FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS THROUGH CO-ADMINISTRATION OF CURCUMIN DERIVATIVE AND TGF-B RECEPTOR INHIBITOR | UNIVERSITY INDUSTRY FOUNDATION, YONSEI UNIVERSITY WONJU CAMPUS (KR) | 2023-11-16 | — | — | US | claimed |
| US-20230365742-A1 | CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD OF PREPARING SAME COMPOUND, EPOXY COMPOSITE MATERIAL CONTAINING SAME COMPOUND, AND METHOD OF DEGRADING SAME COMPOSITE MATERIAL | KONKUK UNIVERSITY INDUSTRIAL COOPERATION CORP (KR) | 2023-11-16 | — | — | US | claimed |
| EP-4248957-A1 | METHOD FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS THROUGH CO-ADMINISTRATION OF CURCUMIN DERIVATIVE AND TGF-? RECEPTOR INHIBITOR | University Industry Foundation, Yonsei University Wonju Campus (KR) | 2023-09-27 | — | — | EP | claimed |
| EP-1433469-B1 | Composition for dyeing keratinous fibres | HENKEL KGAA (DE) | 2006-10-11 | — | — | EP | claimed |
| US-7105032-B2 | Agents used for dyeing keratinous fibers | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2006-09-12 | — | — | US | claimed |
| EP-1434557-B1 | AGENT FOR THE COLORATION OF KERATIN-CONTAINING FIBERS | HENKEL KGAA (DE) | 2005-11-09 | — | — | EP | claimed |
| US-20050144740-A1 | Agents used for dyeing keratinous fibers | HENKEL AG & CO. KGAA (DE) | 2005-07-07 | — | — | US | claimed |
| EP-1292268-B1 | AGENT FOR DYEING KERATIN CONTAINING FIBERS | HENKEL KGAA (DE) | 2005-02-23 | — | — | EP | claimed |
| EP-1292269-B1 | AGENT FOR DYEING KERATIN CONTAINING FIBERS | HENKEL KGAA (DE) | 2005-02-09 | — | — | EP | claimed |
| US-6576660-B1 | Treating prostate cancer, breast cancer, obesity, skin disorders and baldness | ARCH DEVELOPMENT CORPORATION | 2003-06-10 | — | — | US | claimed |
| US-20030082116-A1 | Adhesive compositions containing dual function stabilizers and active agents | CLOSURE MEDICAL CORPORATION (US) | 2003-05-01 | — | — | US | claimed |
| US-6117223-A | Hot melt inks containing polyketones | XEROX CORPORATION (US) | 2000-09-12 | — | — | US | claimed |
| WO-1995018606-A9 | CURCUMIN, ANALOGUES OF CURCUMIN AND NOVEL USES THEREOF | — | 1997-05-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050144740-A1 | Agents used for dyeing keratinous fibers | KRT18, TUBB3, DSG1 | APP 2519/4885CYP2D6 2331/4885NFKB1 2636/4885 |
| US-20260130864-A1 | METHOD AND COMPOSITION FOR ENHANCING EXERCISE PERFORMANCE | SLC6A3, IL17A, HSD17B13 | APP 2617/4885CYP2D6 679/4885NFKB1 3463/4885 |
| US-20030082116-A1 | Adhesive compositions containing dual function stabilizers and active agents | TLN1, PTK2, ILK | APP 2366/4885CYP2D6 4812/4885NFKB1 2471/4885 |
| US-20230364069-A1 | METHOD FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS THROUGH CO-ADMINISTRATION OF CURCUMIN DERIVATIVE AND TGF-B RECEPTOR INHIBITOR | TGFBR2, TGFBR1, TGFB1 | APP 478/4885CYP2D6 1867/4885NFKB1 178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.